Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 18.83% is in line with its 1-year average of 17.44%, near the high end of its 1-year range (16.05%–18.83%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation.
Limited quarterly history available
Debt to Assets needs at least three reported quarters before a meaningful chart is shown.
DEBT TO ASSETS RATIO
18.83%
DEBT TO ASSETS RATIO AVG TTM
N/A
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 638 covered companies
CURRENT VS SECTOR MEDIAN
+18727.69%
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$556.76M
Debt to Assets Ratio
18.83%
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $556.76M | 18.83% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.46M | 0.01% |
| CorMedix Inc. (CRMD)vs › | $564.07M | 0.16% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $568.37M | 0.45% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $554.35M | 0.00% |
| Nuvectis Pharma, Inc. (NVCT)vs › | $545.59M | 0.00% |
| OrthoPediatrics Corp. (KIDS)vs › | $582.66M | 0.18% |
| Delcath Systems, Inc. (DCTH)vs › | $537.16M | 0.02% |
| Immix Biopharma, Inc. (IMMX)vs › | $534.50M | 0.00% |
Debt/Assets
18.8%
Debt/Equity
0.28
Current Ratio
5.42
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 18.83% |
| 2026-03-31 | 16.05% |
